Computerized Decision Support for Identification and Management of Familial Hypercholesterolemia

Study acronym: FH-ALERT
StatusRecruiting
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Lead sponsor: Brigham and Women's Hospital to Brigham and Women's Hospital Show 4 more changesShow less
    • Study completion moved earlier from Dec 31, 2027 to Nov 30, 2027
    • Secondary endpoints: details revised at 1 of 1 entry
    • Site details revised
    • Eligibility criteria expanded, about 4 words
  2. Trial status: Not Yet Recruiting to Recruiting
    • Site details revised
    v2
  3. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
The goal of this clinical trial is to learn if a computer alert can aid clinicians in identifying patients with a genetic type of high cholesterol, called Familial Hypercholesterolemia. The main question it aims to answer is whether the computer alert increases recognition of this high cholesterol disorder.
Trial Details
NCT Number NCT06743659
Lead Sponsor Brigham and Women's Hospital
Conditions
(from sponsor)		 Familial Hypercholesterolaemia
Related terms Hypercholesterolemia, Hyperlipoproteinemia Type II
Enrollment 450 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov